Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AF11167 DDI with Itraconazole in Healthy Subjects
NCT02199431Phase 1Completed
- Sponsor
- Lundbeck
- Start
- Jul 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Lu AF11167 in schizophrenia, sponsored by Lundbeck. Primary endpoints: Area under the plasma concentration-time curve from zero to infinity at Day 8 and Maximum observed plasma concentration at Day 8. Started Jul 2014; status: completed.
02
Drugs
Lu AF11167
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02199431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02199431.